Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Emergency Preparedness and Response

Transcripts - Clinical Trial Designs for Emerging Infectious Diseases Workshop

On November 9-10, 2015, FDA and partners held a workshop to discuss clinical trial designs for emerging infectious diseases. More information about this event is available on the main workshop page.

View the final agenda. (PDF, 330 KB)


Available transcripts from this workshop are listed below, in presentation order. Webcast recordings are also available.

Full combined transcript (PDF, 1.7 MB)

Day 1

Introductory Remarks (PDF, 170 KB) - Luciana Borio View video (7:58)

Opening Presentation - Ian Crozier 

First Panel: The Challenges of Developing New Treatments for Life-Threatening Diseases: From HIV-AIDS to Ebola Virus Disease (EVD)

Reports: WHO R&D Blueprint plus outcomes of London meeting on generating evidence for epidemic infectious diseases (PDF, 191 KB) - David Wood View video(18:16)

Presentation:  Perspectives on clinical trials in emergency situations;decoding language and unveiling assumptions (PDF, 255 KB)  - Steven Goodman View video(38:53)

Commentary (Alex London) and audience Q&A (PDF, 292 KB) - moderator: Lisa LaVange View video (22:14)

Second Panel: Case Studies in Designing  Clinical Trials for Emerging Infectious Diseases

Day 2

Parallel session: Clinical Trial Designs for Preventive Interventions (Vaccines)

Panel: Summary of the Parallel Sessions

Closing Panel: Building on the Past, Looking Towards the Future

Closing remarks (PDF, 175 KB) - Luciana Borio View video (8:22)


Page Last Updated: 01/27/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English